# Excelerate Energy, Inc.: financial statements, quarterly EE · NYSE · CIK 1888447 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ee.md) · [Financials](/companies/ee/financials.md) · [Filings](/companies/ee/filings.md) · [Insiders](/companies/ee/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ee/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [275](/filings/0000950170-24-123531.md) | [240 d](/filings/0001193125-26-078407.md) | [200](/filings/0000950170-25-067156.md) | [183](/filings/0000950170-25-106284.md) | [193](/filings/0001193125-25-269776.md) | [275 d](/filings/0001193125-26-078407.md) | [315](/filings/0001193125-26-212193.md) | [205](/filings/0001193125-26-338466.md) | [391](/filings/0001193125-25-269776.md) | [318 d](/filings/0001193125-26-078407.md) | [433](/filings/0001193125-26-212193.md) | [329](/filings/0001193125-26-338466.md) | | Operating income | $m | [67.5](/filings/0000950170-24-123531.md) | [39.9 d](/filings/0001193125-26-078407.md) | [45.2](/filings/0000950170-25-067156.md) | [49.9](/filings/0000950170-25-106284.md) | [59.7](/filings/0001193125-25-269776.md) | [60.2 d](/filings/0001193125-26-078407.md) | [65.7](/filings/0001193125-26-212193.md) | [43.4](/filings/0001193125-26-338466.md) | [87.2](/filings/0001193125-25-269776.md) | [70.4 d](/filings/0001193125-26-078407.md) | [82.0](/filings/0001193125-26-212193.md) | [80.9](/filings/0001193125-26-338466.md) | | Income tax | $m | [8.2](/filings/0000950170-24-123531.md) | [7.7 d](/filings/0001193125-26-078407.md) | [6.9](/filings/0000950170-25-067156.md) | [7.4](/filings/0000950170-25-106284.md) | [6.2](/filings/0001193125-25-269776.md) | [5.6 d](/filings/0001193125-26-078407.md) | [6.0](/filings/0001193125-26-212193.md) | [5.6](/filings/0001193125-26-338466.md) | [7.9](/filings/0001193125-25-269776.md) | [8.4 d](/filings/0001193125-26-078407.md) | [9.5](/filings/0001193125-26-212193.md) | [(5.9)](/filings/0001193125-26-338466.md) | | Net income | $m | [13.9](/filings/0000950170-24-123531.md) | [3.7 d](/filings/0001193125-26-078407.md) | [6.3](/filings/0000950170-25-067156.md) | [6.7](/filings/0000950170-25-106284.md) | [9.0](/filings/0001193125-25-269776.md) | [10.9 d](/filings/0001193125-26-078407.md) | [11.4](/filings/0001193125-26-212193.md) | [4.7](/filings/0001193125-26-338466.md) | [14.0](/filings/0001193125-25-269776.md) | [9.1 d](/filings/0001193125-26-078407.md) | [12.3](/filings/0001193125-26-212193.md) | [12.1](/filings/0001193125-26-338466.md) | | Diluted EPS | $ per share | [0.40](/filings/0000950170-24-123531.md) | not reported | [0.24](/filings/0000950170-25-067156.md) | [0.26](/filings/0000950170-25-106284.md) | [0.35](/filings/0001193125-25-269776.md) | not reported | [0.46](/filings/0001193125-26-212193.md) | [0.15](/filings/0001193125-26-338466.md) | [0.43](/filings/0001193125-25-269776.md) | not reported | [0.37](/filings/0001193125-26-212193.md) | [0.37](/filings/0001193125-26-338466.md) | | Basic EPS | $ per share | [0.53](/filings/0000950170-24-123531.md) | not reported | [0.24](/filings/0000950170-25-067156.md) | [0.27](/filings/0000950170-25-106284.md) | [0.36](/filings/0001193125-25-269776.md) | not reported | [0.48](/filings/0001193125-26-212193.md) | [0.15](/filings/0001193125-26-338466.md) | [0.44](/filings/0001193125-25-269776.md) | not reported | [0.38](/filings/0001193125-26-212193.md) | [0.38](/filings/0001193125-26-338466.md) | - Revenue: us-gaap:Revenues - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [603](/filings/0000950170-23-062198.md) | [556](/filings/0000950170-25-029147.md) | [579](/filings/0000950170-24-057144.md) | [609](/filings/0000950170-24-094614.md) | [608](/filings/0000950170-24-123531.md) | [538](/filings/0001193125-26-078407.md) | [619](/filings/0000950170-25-067156.md) | [426](/filings/0000950170-25-106284.md) | [463](/filings/0001193125-25-269776.md) | [538](/filings/0001193125-26-338466.md) | [540](/filings/0001193125-26-212193.md) | [342](/filings/0001193125-26-338466.md) | | Current assets | $m | [717](/filings/0000950170-23-062198.md) | [700](/filings/0000950170-25-029147.md) | [694](/filings/0000950170-24-057144.md) | [704](/filings/0000950170-24-094614.md) | [764](/filings/0000950170-24-123531.md) | [754](/filings/0001193125-26-078407.md) | [780](/filings/0000950170-25-067156.md) | [609](/filings/0000950170-25-106284.md) | [695](/filings/0001193125-25-269776.md) | [753](/filings/0001193125-26-338466.md) | [767](/filings/0001193125-26-212193.md) | [595](/filings/0001193125-26-338466.md) | | Total assets | $m | [2,904](/filings/0000950170-23-062198.md) | [2,860](/filings/0000950170-25-029147.md) | [2,858](/filings/0000950170-24-057144.md) | [2,867](/filings/0000950170-24-094614.md) | [2,864](/filings/0000950170-24-123531.md) | [2,883](/filings/0001193125-26-078407.md) | [2,917](/filings/0000950170-25-067156.md) | [4,010](/filings/0000950170-25-106284.md) | [4,097](/filings/0001193125-25-269776.md) | [4,131](/filings/0001193125-26-338466.md) | [4,135](/filings/0001193125-26-212193.md) | [4,163](/filings/0001193125-26-338466.md) | | Current liabilities | $m | [173](/filings/0000950170-23-062198.md) | [204](/filings/0000950170-25-029147.md) | [197](/filings/0000950170-24-057144.md) | [205](/filings/0000950170-24-094614.md) | [185](/filings/0000950170-24-123531.md) | [216](/filings/0001193125-26-078407.md) | [233](/filings/0000950170-25-067156.md) | [234](/filings/0000950170-25-106284.md) | [291](/filings/0001193125-25-269776.md) | [310](/filings/0001193125-26-338466.md) | [295](/filings/0001193125-26-212193.md) | [331](/filings/0001193125-26-338466.md) | | Total liabilities | $m | [1,101](/filings/0000950170-23-062198.md) | [1,051](/filings/0000950170-25-029147.md) | [1,029](/filings/0000950170-24-057144.md) | [1,019](/filings/0000950170-24-094614.md) | [982](/filings/0000950170-24-123531.md) | [995](/filings/0001193125-26-078407.md) | [986](/filings/0000950170-25-067156.md) | [1,861](/filings/0000950170-25-106284.md) | [1,902](/filings/0001193125-25-269776.md) | [1,902](/filings/0001193125-26-338466.md) | [1,880](/filings/0001193125-26-212193.md) | [1,891](/filings/0001193125-26-338466.md) | | Long-term debt | $m | [400](/filings/0000950170-23-062198.md) | [333](/filings/0000950170-25-029147.md) | [323](/filings/0000950170-24-057144.md) | [310](/filings/0000950170-24-094614.md) | [299](/filings/0000950170-24-123531.md) | [287](/filings/0001193125-26-078407.md) | [276](/filings/0000950170-25-067156.md) | [926](/filings/0000950170-25-106284.md) | [919](/filings/0001193125-25-269776.md) | [913](/filings/0001193125-26-338466.md) | [908](/filings/0001193125-26-212193.md) | [902](/filings/0001193125-26-338466.md) | | Current portion of debt | $m | [40.7](/filings/0000950170-23-062198.md) | [42.6](/filings/0000950170-25-029147.md) | [44.4](/filings/0000950170-24-057144.md) | [46.2](/filings/0000950170-24-094614.md) | [46.4](/filings/0000950170-24-123531.md) | [46.8](/filings/0001193125-26-078407.md) | [47.0](/filings/0000950170-25-067156.md) | [20.1](/filings/0000950170-25-106284.md) | [23.2](/filings/0001193125-25-269776.md) | [23.5](/filings/0001193125-26-338466.md) | [23.7](/filings/0001193125-26-212193.md) | [24.0](/filings/0001193125-26-338466.md) | | Shareholders' equity | $m | [1,803](/filings/0000950170-24-123531.md) | [1,809](/filings/0001193125-26-078407.md) | [1,828](/filings/0001193125-25-269776.md) | [1,849](/filings/0001193125-25-269776.md) | [1,883](/filings/0001193125-25-269776.md) | [1,889](/filings/0001193125-26-338466.md) | [1,932](/filings/0001193125-26-338466.md) | [2,149](/filings/0001193125-26-338466.md) | [2,195](/filings/0001193125-25-269776.md) | [2,229](/filings/0001193125-26-338466.md) | [2,255](/filings/0001193125-26-338466.md) | [2,272](/filings/0001193125-26-338466.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [171 d](/filings/0000950170-24-123531.md) | [36.6 d](/filings/0001193125-26-078407.md) | [64.7](/filings/0000950170-25-067156.md) | [90.4 d](/filings/0000950170-25-106284.md) | [39.8 d](/filings/0001193125-25-269776.md) | [49.6 d](/filings/0001193125-26-078407.md) | [155](/filings/0001193125-26-212193.md) | [87.1 d](/filings/0001193125-26-338466.md) | [115 d](/filings/0001193125-25-269776.md) | [104 d](/filings/0001193125-26-078407.md) | [60.0](/filings/0001193125-26-212193.md) | [114 d](/filings/0001193125-26-338466.md) | | Dividends paid | $m | [0.7 d](/filings/0000950170-24-123531.md) | [0.7 d](/filings/0001193125-26-078407.md) | [0.7](/filings/0000950170-25-067156.md) | [0.6 d](/filings/0000950170-25-106284.md) | [0.8 d](/filings/0001193125-25-269776.md) | [1.3 d](/filings/0001193125-26-078407.md) | [1.5](/filings/0001193125-26-212193.md) | [1.9 d](/filings/0001193125-26-338466.md) | [2.6 d](/filings/0001193125-25-269776.md) | [2.6 d](/filings/0001193125-26-078407.md) | [2.7](/filings/0001193125-26-212193.md) | [2.5 d](/filings/0001193125-26-338466.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Dividends paid: us-gaap:PaymentsOfDividends ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [26.3](/filings/0000950170-23-062198.md) | [26.3](/filings/0000950170-24-057144.md) | [26.3](/filings/0000950170-24-094614.md) | [108](/filings/0000950170-24-123531.md) | [26.2](/filings/0000950170-25-067156.md) | [25.3](/filings/0000950170-25-106284.md) | [25.5](/filings/0001193125-25-269776.md) | [107](/filings/0001193125-26-212193.md) | [32.2](/filings/0001193125-26-338466.md) | [32.7](/filings/0001193125-25-269776.md) | [33.0](/filings/0001193125-26-212193.md) | [32.4](/filings/0001193125-26-338466.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.